Antifungal resistance findings of the Spanish fungemia surveillance multicentre study (FUNGEMYCA. Are there any differences between ICU and non-ICU patients?

Zaragoza R1, Pemán J2, Cantón E2, Camarena J1, Ayats J3, Torroba L4, Navarro D5, Royo G6, Echevarria J7, Martinez J8, Guna R9, Ramirez I10, and the Spanish FUNGEMYCA group.

Author address: 

1Hosp. Univ. Dr. Peset, Valencia, Spain; Hosp ; Hospital Univ. La Fe Spain; 3Hospital Universitari de Bellvitge,Spain; 4Hospital Universitario Virgen del Camino, Pamplona, Spain; 5Hospital Clí­nico Universitario, Valencia, Spain; 6Hospital General Un


The introduction of new antifungal agents together with the emergence of new fungal species with unknown susceptibility requires surveillance for the detection of isolates with decreased susceptibility to antifungal agents, especially in critical care setting, in order to optimize the antifungal treatment. The aim of this study was to determine whether there are any differences in the antifungal agent resistance rates between ICU and non ICU adult patients in the age of new agents.

abstract No: 


Full conference title: 

22nd European Congress of Clinical Microbiology and Infectious Diseases
    • ECCMID 22nd (2012)